NCT03854552View on ClinicalTrials.gov

A Study in Healthy Men Tests How Different Doses of BI 764198 Are Taken up in the Body and How Well They Are Tolerated.

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

March 15, 2019

Primary Completion Date

August 7, 2019

Study Completion Date

August 7, 2019

Conditions
Healthy
Interventions
DRUG

BI 764198

capsule

DRUG

Placebo

capsule

Trial Locations (1)

68167

CRS Clinical Research Services Mannheim GmbH, Mannheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03854552 - A Study in Healthy Men Tests How Different Doses of BI 764198 Are Taken up in the Body and How Well They Are Tolerated. | Biotech Hunter | Biotech Hunter